They specifically note a decrease in the expression of the BDNF and SIRT1 genes, and an increase in the expression of miR-132-3p, miR-34a, and miR-132 in PBMCs, of MS patients, suggesting that the investigated miRNAs may regulate the expression-level genes under study. The gene discussed is SIRT1; the disease is myeloid sarcoma.